Results 31 to 40 of about 22,017 (305)

Neopterin: A Promising Candidate Biomarker for Severe COVID-19

open access: yesJournal of Inflammation Research, 2021
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection has rapidly spread across the world since its first emergence in China in late 2019. It is a major public health concern with no effective treatct 3ments.
Wasihun Hailemichael   +4 more
semanticscholar   +1 more source

Urinary neopterin concentrations vs total neopterins for clinical utility. [PDF]

open access: yesClinical Chemistry, 1989
Abstract Neopterin measurements are especially useful as an early marker in (e.g.) allograft rejections and in patients infected with human immunodeficiency virus type 1 (HIV-1). An increased concentration of total neopterins (neopterin + dihydroneopterin) is also a significant marker in patients with HIV-1 infection.
Fuchs, Dietmar   +7 more
openaire   +3 more sources

Cerebrospinal fluid neopterin as a biomarker of treatment response to Janus kinase inhibition in Aicardi–Goutières syndrome

open access: yesDevelopmental Medicine & Child Neurology, 2021
Janus kinase (JAK) 1 inhibition represents a precision medicine approach in the treatment of Aicardi–Goutières syndrome (AGS), through targeting of type I interferon‐mediated cell signalling.
V. Han   +5 more
semanticscholar   +1 more source

Increased Fecal Neopterin Parallels Gastrointestinal Symptoms in COVID-19

open access: yesClinical and Translational Gastroenterology, 2021
INTRODUCTION: Coronavirus disease (COVID-19) has spread from Wuhan, China, and become a worldwide pandemic. Most patients display respiratory symptoms but up to 50% report gastrointestinal symptoms. Neopterin is a surrogate marker for viral inflammation,
F. Grabherr   +15 more
semanticscholar   +1 more source

Serum neopterin levels in relation to mild and severe COVID-19

open access: yesBMC Infectious Diseases, 2020
Background The COVID-19 pandemic, caused by the coronavirus SARS-CoV-2, is rapidly spreading worldwide. There is limited information about prognostic markers that could help clinicians to identify COVID-19 patients with a poor prognosis.
Josefina Robertson   +5 more
semanticscholar   +1 more source

Neopterin is a biomarker of chronic heart failure (review of modern literature)

open access: yesConsilium Medicum, 2021
Inflammation plays a role in the pathogenesis of heart failure. Neopterin, pteridine, synthesized mainly by activated macrophages, is a marker of inflammation, activation of the immune system, and an active participant in cardiovascular disease ...
A. M. Alieva   +9 more
semanticscholar   +1 more source

Fibroblast growth factors 1 and 2 in cerebrospinal fluid are associated with HIV disease, methamphetamine use, and neurocognitive functioning. [PDF]

open access: yes, 2016
BackgroundHuman immunodeficiency virus (HIV) and methamphetamine use commonly affect neurocognitive (NC) functioning. We evaluated the relationships between NC functioning and two fibroblast growth factors (FGFs) in volunteers who differed in HIV ...
Bharti, Ajay R   +10 more
core   +2 more sources

Cerebrospinal Fluid Concentrations of the Synaptic Marker Neurogranin in Neuro-HIV and Other Neurological Disorders. [PDF]

open access: yes, 2019
Purpose of reviewThe aim of this study was to examine the synaptic biomarker neurogranin in cerebrospinal fluid (CSF) in different stages of HIV infection and in relation to what is known about CSF neurogranin in other neurodegenerative diseases.Recent ...
Blennow, Kaj   +6 more
core   +2 more sources

Biomarkers of Tuberculosis Severity and Treatment Effect: A Directed Screen of 70 Host Markers in a Randomized Clinical Trial. [PDF]

open access: yes, 2017
More efficacious treatment regimens are needed for tuberculosis, however, drug development is impeded by a lack of reliable biomarkers of disease severity and of treatment effect. We conducted a directed screen of host biomarkers in participants enrolled
Barbero, S   +14 more
core   +2 more sources

Evaluating predictive markers for viral rebound and safety assessment in blood and lumbar fluid during HIV-1 treatment interruption [PDF]

open access: yes, 2020
Background: Validated biomarkers to evaluate HIV-1 cure strategies are currently lacking, therefore requiring analytical treatment interruption (ATI) in study participants.
De Langhe, Nele   +15 more
core   +1 more source

Home - About - Disclaimer - Privacy